Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype

被引:318
作者
Hagemann, Thorsten
Wilson, Julia
Burke, Frances
Kulbe, Hagen
Li, Ninfeng Fiona
Pluddemann, Annette
Charles, Kellie
Gordon, Siamon
Balkwill, Frances R.
机构
[1] John Vane Sci Ctr, Queen Marys Sch Med & Dent, Canc Res UK Translat Oncol Lab, London EC1M 6BQ, England
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
基金
英国医学研究理事会;
关键词
D O I
10.4049/jimmunol.176.8.5023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-associated macrophages (TAM) may have tumor-promoting activity, but it is not clear how their phenotype is achieved. In this study, we demonstrate that ovarian cancer cells switch cocultured macrophages to a phenotype similar to that found in ovarian tumors. Tumor cells caused dynamic changes in macrophage cytokine, chemokine, and matrix metalloprotease mRNA, and protein-inducing mediators that are found in human cancer. Macrophage mannose, mannose receptor, and scavenger receptors (SR-As) were also up-regulated by coculture, but not by conditioned medium. To further validate the model, we studied SR-A regulation on TAM in vitro and in vivo. Coculture of murine macrophages from mice deficient in TNF-alpha or its receptors revealed that TNF-alpha was key to SR-A induction via its p75 receptor. SR-A expression was also reduced in TAM from ovarian cancers treated with anti-TNF-alpha Abs or grown in TNF-alpha(-/-) mice. Chemical communication between tumor cells and macrophages may be important in regulating the cancer cytokine microenvironment.
引用
收藏
页码:5023 / 5032
页数:10
相关论文
共 42 条
[1]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[2]  
2-4
[3]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[4]   Smoldering and polarized inflammation in the initiation and promotion of malignant disease [J].
Balkwill, F ;
Charles, KA ;
Mantovani, A .
CANCER CELL, 2005, 7 (03) :211-217
[5]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[6]  
BENARD J, 1985, CANCER RES, V45, P4970
[7]   The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies [J].
Bingle, L ;
Brown, NJ ;
Lewis, CE .
JOURNAL OF PATHOLOGY, 2002, 196 (03) :254-265
[8]   A cytokine profile of normal and malignant ovary [J].
Burke, F ;
Relf, M ;
Negus, R ;
Balkwill, F .
CYTOKINE, 1996, 8 (07) :578-585
[9]  
CHAMBERS SK, 1995, CANCER RES, V55, P1578
[10]   Inflammatory cells and cancer: Think different! [J].
Coussens, LM ;
Werb, Z .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (06) :F23-F26